AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,904 | +11.7% | 31,020 | -63.2% | 0.00% | – |
| Q1 2023 | $117,188 | +155.4% | 84,308 | +265.7% | 0.00% | – |
| Q4 2022 | $45,883 | -73.9% | 23,057 | -58.3% | 0.00% | -100.0% |
| Q2 2022 | $176,000 | -53.4% | 55,303 | -39.0% | 0.00% | -50.0% |
| Q1 2022 | $378,000 | +51.2% | 90,608 | +73.3% | 0.00% | +100.0% |
| Q4 2021 | $250,000 | -15.3% | 52,287 | -5.5% | 0.00% | 0.0% |
| Q3 2021 | $295,000 | -22.8% | 55,326 | -25.8% | 0.00% | 0.0% |
| Q2 2021 | $382,000 | -10.1% | 74,599 | -19.8% | 0.00% | -66.7% |
| Q4 2020 | $425,000 | -33.1% | 93,034 | -43.2% | 0.00% | -66.7% |
| Q3 2020 | $635,000 | +1033.9% | 163,757 | +1296.1% | 0.01% | +800.0% |
| Q2 2020 | $56,000 | -58.2% | 11,730 | -69.5% | 0.00% | -66.7% |
| Q1 2020 | $134,000 | -93.1% | 38,437 | -90.5% | 0.00% | -75.0% |
| Q4 2019 | $1,942,000 | +63.3% | 402,908 | -1.7% | 0.01% | +9.1% |
| Q3 2019 | $1,189,000 | -70.7% | 410,003 | +43.0% | 0.01% | -74.4% |
| Q1 2019 | $4,064,000 | +325.5% | 286,808 | +306.5% | 0.04% | +290.9% |
| Q4 2018 | $955,000 | – | 70,557 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $102,442,000 | 9.84% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $77,176,000 | 1.36% |
| Sivik Global Healthcare LLC | 600,000 | $2,856,000 | 0.95% |
| THB ASSET MANAGEMENT | 651,150 | $3,099,000 | 0.90% |
| Eversept Partners, LP | 886,587 | $4,220,154 | 0.58% |
| Spark Investment Management LLC | 30,100 | $143,000 | 0.52% |
| GLOBEFLEX CAPITAL L P | 240,680 | $1,146,000 | 0.29% |
| Alambic Investment Management, L.P. | 19,493 | $93,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 49,901 | $238,000 | 0.13% |
| C M BIDWELL & ASSOCIATES LTD | 29,550 | $141,000 | 0.13% |